In determining multiple
primaries, separate rules are used for non-malignant and malignant
brain tumors. Rules are based on the specific data elements.
Timing (assuming same site and same histology)
- Malignant: 2 months
- Non-malignant: no limitation
The current timing rule for determining multiple primary
tumors applies to malignant CNS tumors only. If two or more
primary malignant intracranial or CNS tumors are diagnosed
in the same site within two months of the diagnosis of the
first primary, the tumors are counted as one primary. If multiple
tumors of the same site are diagnosed more than two months
apart, the tumors are counted as separate primary sites.
The current 2 month rule does not apply to non-malignant
CNS tumors. Non-malignant tumors may recur in the same location.
If they recur, even after 20 years, they are still the same
tumor.
Site
- Malignant: 3 character level
- Non-malignant: 4 character level
For non-malignant CNS tumors, sites are different when there
is a difference in the 4th digit of the site code, but the
first 3 digits are the same. For example, spinal meninges
(C70.1) and cerebral meninges (C70.0) are considered different
primaries. (The exception is when the difference in the 4th
digit occurs because the 4th digit of one site code is 9,
which indicates a non-specific code.)
Malignant tumors remain as they are currently defined with
differences only at the 3 digit level. Therefore, separate
malignant tumors occurring in the cerebral meninges and in
the spinal meninges (both C70) are not considered different
primaries.
Laterality
Laterality should be coded for both non-malignant and malignant
brain
tumors. Further, laterality is to be considered when determining
multiple primaries for non-malignant tumors but not for malignant
brain tumors.
CNS sites to be coded with laterality:
- Cerebral meninges, NOS (C70.0)
- Cerebrum (C71.0)
- Frontal lobe (C71.1)
- Temporal lobe (C71.2)
- Parietal lobe (C71.3)
- Occipital lobe (C71.4)
- Olfactory nerve (C72.2)
- Optic nerve (C72.3)
- Acoustic nerve (C72.4)
- Cranial nerve, NOS (C72.5)
Code laterality using codes 1 through 4 or 9 (paired site
but lateral origin unknown; midline tumor). The laterality
for all other CNS sites is coded 0 (not a paired organ).
Histology
- Malignant: 3 digit level
- Non-malignant: Histology Groups Table
The histology rules for counting multiple primaries
have to be modified to count tumors at a level other than
the first three digits of the morphology code.
The evolution and grading of brain tumors is such that a
tumor may recur at a higher grade which has a different ICD-O-3
code number. In such cases, the new tumor is not counted as
a new primary (except if it progresses or transforms from
benign or borderline to malignant). The various four-digit
histologies within each of these histologic groups will be
counted as one primary. Thus the patient could have one glioma
and one ependymoma, but not a low grade astrocytoma followed
by a glioblastoma multiforme at the same site.
For counting non-malignant primaries, each of
the following groups is considered ONE primary.
Histologic groupings to determine same histology for non-malignant
brain tumors
| Choroid plexus neoplasms |
9390/0, 9390/1 |
| Ependymomas |
9383, 9394, 9444, |
| Neuronal and neuronal-glial neoplasms |
9384, 9412, 9413, 9442, 9505/1, 9506 |
Neurofibromas
|
9540/0, 9540/1, 9541, 9550, 9560/0 |
| Neurinomatosis |
9560/1 |
| Neurothekeoma |
9562 |
Neuroma
|
9570 |
Perineurioma, NOS
|
9571/0 |
Please use the two reference tables below to count malignant
and non-malignant primaries.
B = Benign
M = Malignant



|